HIV Drugs Global Market Report 2025

HIV Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hiv drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for hiv drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hiv drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs), Other Types

2) By Administration: Oral, Parenteral

3) By Application: Hospital Pharmacies, Retail Pharmacies, Other Applications

Subsegments:

1) By Nucleoside Reverse Transcriptase Inhibitors (NRTIs): Zidovudine (AZT); Lamivudine (3TC); Abacavir (ABC); Tenofovir disoproxil fumarate (TDF); Other NRTIs

2) By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Efavirenz (EFV); Nevirapine (NVP); Etravirine (ETR); Rilpivirine (RPV); Other NNRTIs

3) By Protease Inhibitors (PIs): Ritonavir (RTV); Lopinavir (LPV); Darunavir (DRV); Atazanavir (ATV); Other PIs

4) By Integrase Strand Transfer Inhibitors (INSTIs): Raltegravir (RAL); Dolutegravir (DTG); Bictegravir (BIC); Other INSTIs

5) By Other Types: Entry Inhibitors; Fusion Inhibitors; Combination Therapies

Companies Mentioned: Gilead Sciences Inc.; Johnson & Johnson; Merck & Co. Inc.; Boehringer Ingelheim International GmbH; Cipla

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.


1. Executive Summary
2. HIV Drugs Market Characteristics
3. HIV Drugs Market Trends And Strategies
4. HIV Drugs Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global HIV Drugs Growth Analysis And Strategic Analysis Framework
5.1. Global HIV Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global HIV Drugs Market Growth Rate Analysis
5.4. Global HIV Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global HIV Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global HIV Drugs Total Addressable Market (TAM)
6. HIV Drugs Market Segmentation
6.1. Global HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nucleoside Reverse Transcriptase Inhibitors (NRT’s)
Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s)
Protease Inhibitors
Integrase strand transfer inhibitors (INSTIs)
Other Types
6.2. Global HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
6.3. Global HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Other Applications
6.4. Global HIV Drugs Market, Sub-Segmentation Of Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Zidovudine (AZT)
Lamivudine (3TC)
Abacavir (ABC)
Tenofovir disoproxil fumarate (TDF)
Other NRTIs
6.5. Global HIV Drugs Market, Sub-Segmentation Of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Efavirenz (EFV)
Nevirapine (NVP)
Etravirine (ETR)
Rilpivirine (RPV)
Other NNRTIs
6.6. Global HIV Drugs Market, Sub-Segmentation Of Protease Inhibitors (PIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ritonavir (RTV)
Lopinavir (LPV)
Darunavir (DRV)
Atazanavir (ATV)
Other PIs
6.7. Global HIV Drugs Market, Sub-Segmentation Of Integrase Strand Transfer Inhibitors (INSTIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Raltegravir (RAL)
Dolutegravir (DTG)
Bictegravir (BIC)
Other INSTIs
6.8. Global HIV Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Entry Inhibitors
Fusion Inhibitors
Combination Therapies
7. HIV Drugs Market Regional And Country Analysis
7.1. Global HIV Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global HIV Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific HIV Drugs Market
8.1. Asia-Pacific HIV Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China HIV Drugs Market
9.1. China HIV Drugs Market Overview
9.2. China HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India HIV Drugs Market
10.1. India HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan HIV Drugs Market
11.1. Japan HIV Drugs Market Overview
11.2. Japan HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia HIV Drugs Market
12.1. Australia HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia HIV Drugs Market
13.1. Indonesia HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea HIV Drugs Market
14.1. South Korea HIV Drugs Market Overview
14.2. South Korea HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe HIV Drugs Market
15.1. Western Europe HIV Drugs Market Overview
15.2. Western Europe HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK HIV Drugs Market
16.1. UK HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany HIV Drugs Market
17.1. Germany HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France HIV Drugs Market
18.1. France HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy HIV Drugs Market
19.1. Italy HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain HIV Drugs Market
20.1. Spain HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe HIV Drugs Market
21.1. Eastern Europe HIV Drugs Market Overview
21.2. Eastern Europe HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia HIV Drugs Market
22.1. Russia HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America HIV Drugs Market
23.1. North America HIV Drugs Market Overview
23.2. North America HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA HIV Drugs Market
24.1. USA HIV Drugs Market Overview
24.2. USA HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada HIV Drugs Market
25.1. Canada HIV Drugs Market Overview
25.2. Canada HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America HIV Drugs Market
26.1. South America HIV Drugs Market Overview
26.2. South America HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil HIV Drugs Market
27.1. Brazil HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East HIV Drugs Market
28.1. Middle East HIV Drugs Market Overview
28.2. Middle East HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa HIV Drugs Market
29.1. Africa HIV Drugs Market Overview
29.2. Africa HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. HIV Drugs Market Competitive Landscape And Company Profiles
30.1. HIV Drugs Market Competitive Landscape
30.2. HIV Drugs Market Company Profiles
30.2.1. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Cipla Overview, Products and Services, Strategy and Financial Analysis
31. HIV Drugs Market Other Major And Innovative Companies
31.1. Aurobindo Pharma
31.2. AbbVie
31.3. Emcure Pharmaceuticals
31.4. Micro Labs Limited
31.5. Northeast Pharmaceutical Group Co. Ltd
31.6. Dr. Reddy's Laboratories Ltd.
31.7. Sun Pharmaceutical Industries Ltd
31.8. Strides Arcolab Limited
31.9. Hetero Labs Limited
31.10. Shanghai Desano Bio-pharmaceutical Co.
31.11. Anhui Biochem Biopharmaceutical Co. Ltd.
31.12. China's National Health Commission (NHC)
31.13. Shanghai Xinxing Medicine Co. Ltd.
31.14. China Meheco Xinxing Pharma Co. Ltd.
31.15. CytoDyn Inc.
32. Global HIV Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The HIV Drugs Market
34. Recent Developments In The HIV Drugs Market
35. HIV Drugs Market High Potential Countries, Segments and Strategies
35.1 HIV Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 HIV Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 HIV Drugs Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings